217 related articles for article (PubMed ID: 35430564)
1. Deletion of
Aoki Y; Tome Y; Han Q; Yamamoto J; Hamada K; Masaki N; Kubota Y; Bouvet M; Nishida K; Hoffman RM
Cancer Genomics Proteomics; 2022; 19(3):299-304. PubMed ID: 35430564
[TBL] [Abstract][Full Text] [Related]
2. Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma.
García-Castellano JM; Villanueva A; Healey JH; Sowers R; Cordon-Cardo C; Huvos A; Bertino JR; Meyers P; Gorlick R
Clin Cancer Res; 2002 Mar; 8(3):782-7. PubMed ID: 11895909
[TBL] [Abstract][Full Text] [Related]
3. The Combination of Methioninase and Ethionine Exploits Methionine Addiction to Selectively Eradicate Osteosarcoma Cells and Not Normal Cells and Synergistically Down-regulates the Expression of
Aoki Y; Kubota Y; Han Q; Masaki N; Obara K; Bouvet M; Chawla SP; Tome Y; Nishida K; Hoffman RM
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):679-685. PubMed ID: 38035708
[TBL] [Abstract][Full Text] [Related]
4. Methylthioadenosine phosphorylase deficiency in Japanese osteosarcoma patients.
Miyazaki S; Nishioka J; Shiraishi T; Matsumine A; Uchida A; Nobori T
Int J Oncol; 2007 Nov; 31(5):1069-76. PubMed ID: 17912432
[TBL] [Abstract][Full Text] [Related]
5. Effective Metabolic Targeting of Human Osteosarcoma Cells
Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Murakami T; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Hoffman RM
Anticancer Res; 2017 Sep; 37(9):4807-4812. PubMed ID: 28870899
[TBL] [Abstract][Full Text] [Related]
6. Methylthioadenosine phosphorylase cDNA transfection alters sensitivity to depletion of purine and methionine in A549 lung cancer cells.
Hori H; Tran P; Carrera CJ; Hori Y; Rosenbach MD; Carson DA; Nobori T
Cancer Res; 1996 Dec; 56(24):5653-8. PubMed ID: 8971171
[TBL] [Abstract][Full Text] [Related]
7. Oral-recombinant Methioninase in Combination With Rapamycin Eradicates Osteosarcoma of the Breast in a Patient-derived Orthotopic Xenograft Mouse Model.
Masaki N; Han Q; Samonte C; Wu NF; Hozumi C; Wu J; Obara K; Kubota Y; Aoki Y; Bouvet M; Hoffman RM
Anticancer Res; 2022 Nov; 42(11):5217-5222. PubMed ID: 36288875
[TBL] [Abstract][Full Text] [Related]
8. Polyamine Inhibitor SAM486A Augments Cytarabine Cytotoxicity in Methylthioadenosine Phosphorylase-deficient Leukemia Cells.
Nishi R; Fujita K; Matsuda Y; Kamatani N; Yamauchi T
Anticancer Res; 2024 Mar; 44(3):981-991. PubMed ID: 38423659
[TBL] [Abstract][Full Text] [Related]
9. Defects in methylthioadenosine phosphorylase are associated with but not responsible for methionine-dependent tumor cell growth.
Tang B; Li YN; Kruger WD
Cancer Res; 2000 Oct; 60(19):5543-7. PubMed ID: 11034100
[TBL] [Abstract][Full Text] [Related]
10. Expression of methylthioadenosine phosphorylase cDNA in p16-, MTAP- malignant cells: restoration of methylthioadenosine phosphorylase-dependent salvage pathways and alterations of sensitivity to inhibitors of purine de novo synthesis.
Chen ZH; Olopade OI; Savarese TM
Mol Pharmacol; 1997 Nov; 52(5):903-11. PubMed ID: 9351982
[TBL] [Abstract][Full Text] [Related]
11. Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5.
Mavrakis KJ; McDonald ER; Schlabach MR; Billy E; Hoffman GR; deWeck A; Ruddy DA; Venkatesan K; Yu J; McAllister G; Stump M; deBeaumont R; Ho S; Yue Y; Liu Y; Yan-Neale Y; Yang G; Lin F; Yin H; Gao H; Kipp DR; Zhao S; McNamara JT; Sprague ER; Zheng B; Lin Y; Cho YS; Gu J; Crawford K; Ciccone D; Vitari AC; Lai A; Capka V; Hurov K; Porter JA; Tallarico J; Mickanin C; Lees E; Pagliarini R; Keen N; Schmelzle T; Hofmann F; Stegmeier F; Sellers WR
Science; 2016 Mar; 351(6278):1208-13. PubMed ID: 26912361
[TBL] [Abstract][Full Text] [Related]
12. Frequent deletion in the methylthioadenosine phosphorylase gene in T-cell acute lymphoblastic leukemia: strategies for enzyme-targeted therapy.
Batova A; Diccianni MB; Nobori T; Vu T; Yu J; Bridgeman L; Yu AL
Blood; 1996 Oct; 88(8):3083-90. PubMed ID: 8874207
[TBL] [Abstract][Full Text] [Related]
13. Methods to Study the Role of Methionine-Restricted Diet and Methioninase in Cancer Growth Control.
Chaturvedi S; Bertino JR
Methods Mol Biol; 2019; 1866():1-12. PubMed ID: 30725403
[TBL] [Abstract][Full Text] [Related]
14. Oral-recombinant Methioninase Converts an Osteosarcoma from Methotrexate-resistant to -sensitive in a Patient-derived Orthotopic-xenograft (PDOX) Mouse Model.
Aoki Y; Tome Y; Han Q; Yamamoto J; Hamada K; Masaki N; Kubota Y; Bouvet M; Nishida K; Hoffman RM
Anticancer Res; 2022 Feb; 42(2):731-737. PubMed ID: 35093871
[TBL] [Abstract][Full Text] [Related]
15. Oncogenes and Methionine Addiction of Cancer: Role of
Aoki Y; Han Q; Kubota Y; Masaki N; Obara K; Tome Y; Bouvet M; Nishida K; Hoffman RM
Cancer Genomics Proteomics; 2023; 20(2):165-170. PubMed ID: 36870694
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy targeting methylthioadenosine phosphorylase (MTAP) deficiency in adult T cell leukemia (ATL).
Harasawa H; Yamada Y; Kudoh M; Sugahara K; Soda H; Hirakata Y; Sasaki H; Ikeda S; Matsuo T; Tomonaga M; Nobori T; Kamihira S
Leukemia; 2002 Sep; 16(9):1799-807. PubMed ID: 12200696
[TBL] [Abstract][Full Text] [Related]
17. Methylthioadenosine phosphorylase regulates ornithine decarboxylase by production of downstream metabolites.
Subhi AL; Diegelman P; Porter CW; Tang B; Lu ZJ; Markham GD; Kruger WD
J Biol Chem; 2003 Dec; 278(50):49868-73. PubMed ID: 14506228
[TBL] [Abstract][Full Text] [Related]
18. Exploiting methionine restriction for cancer treatment.
Chaturvedi S; Hoffman RM; Bertino JR
Biochem Pharmacol; 2018 Aug; 154():170-173. PubMed ID: 29733806
[TBL] [Abstract][Full Text] [Related]
19. Oral-recombinant Methioninase Lowers the Effective Dose and Eliminates Toxicity of Cisplatinum for Primary Osteosarcoma of the Mammary Gland in a Patient-derived Orthotopic Xenograft Mouse Model.
Masaki N; Han Q; Wu NF; Samonte C; Wu J; Hozumi C; Obara K; Kubota Y; Aoki Y; Miyazaki J; Hoffman RM
In Vivo; 2022; 36(6):2598-2603. PubMed ID: 36309364
[TBL] [Abstract][Full Text] [Related]
20. Synergy of oral recombinant methioninase (rMETase) and 5-fluorouracil on poorly differentiated gastric cancer.
Miyake M; Miyake K; Han Q; Igarashi K; Kawaguchi K; Barangi M; Kiyuna T; Sugisawa N; Higuchi T; Oshiro H; Zhang Z; Razmjooei S; Bouvet M; Endo I; Hoffman RM
Biochem Biophys Res Commun; 2023 Feb; 643():48-54. PubMed ID: 36586158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
